Cite
Cost-effectiveness of Breast Cancer Screening With Magnetic Resonance Imaging for Women at Familial Risk
MLA
Geuzinge, H.Amarens, et al. “Cost-Effectiveness of Breast Cancer Screening With Magnetic Resonance Imaging for Women at Familial Risk.” JAMA Oncology, vol. 6, no. 9, Sept. 2020, pp. 1381–89. EBSCOhost, https://doi.org/10.1001/jamaoncol.2020.2922.
APA
Geuzinge, H. A., Obdeijn, I.-M., Rutgers, E. J. T., Saadatmand, S., Mann, R. M., Oosterwijk, J. C., Tollenaar, R. A. E. M., de Roy van Zuidewijn, D. B. W., Lobbes, M. B. I., van, t R. M., Hooning, M. J., Ausems, M. G. E. M., Loo, C. E., Wesseling, J., Luiten, E. J. T., Zonderland, H. M., Verhoef, C., Heijnsdijk, E. A. M., Tilanus-Linthorst, M. M. A., & de Koning, H. J. (2020). Cost-effectiveness of Breast Cancer Screening With Magnetic Resonance Imaging for Women at Familial Risk. JAMA Oncology, 6(9), 1381–1389. https://doi.org/10.1001/jamaoncol.2020.2922
Chicago
Geuzinge, H. Amarens, Inge-Marie Obdeijn, Emiel J. T. Rutgers, Sepideh Saadatmand, Ritse M. Mann, Jan C. Oosterwijk, Rob A. E. M. Tollenaar, et al. 2020. “Cost-Effectiveness of Breast Cancer Screening With Magnetic Resonance Imaging for Women at Familial Risk.” JAMA Oncology 6 (9): 1381–89. doi:10.1001/jamaoncol.2020.2922.